Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Pignot

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Deutsche Medizinische Wochenschrift (1946)|March 13, 2024
[Clinical courses and costs for hospitalizations of potentially immunocompromised COVID-19 patients in Germany]Dennis Häckl, Marc Pignot, Phi Long Dang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 11, 2023
Comorbidities, healthcare resource utilization & treatment pattern among patients with prurigo nodularis, compared to a benchmark in Germany: A real-world evidence claims data studySonja Ständer, Miriam Ketz, Divine Akumo, et al.
Acta Dermato-Venereologica|October 6, 2020
Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database AnalysisSonja Ständer, Miriam Ketz, Nils Kossack, et al.
Rheumatology and Therapy|November 24, 2023
Real-World Burden of Immunosuppressant-Treated Lupus Nephritis: A German Claims Database AnalysisElena Garal-Pantaler, Michael Schultze, Mary Elizabeth Georgiou, et al.
Acta Ophthalmologica|September 9, 2025
Epidemiology and burden of mild/moderate versus high myopia in Germany: A claims data analysisTarcyane Barata Garcia, Nils Kossack, Marc Pignot, et al.
Clinical and Experimental Rheumatology|February 12, 2026
Systemic lupus erythematosus and associated organ damage in real-world settings: estimating damage scores using administrative claims dataMichael Schultze, Elena Garal-Pantaler, Marc Pignot, et al.
BMC Rheumatology|May 16, 2024
Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in GermanyMichael Schultze, Elena Garal-Pantaler, Marc Pignot, et al.
Advances in Therapy|June 12, 2026
Incidence, Healthcare Resource Utilization, and Costs Associated with Intraoperative Ureteral Injuries: Evidence from a German Claims DatabaseBogdan Muresan, Tobias Heidler, Kirsten Leyland, et al.
Infectious Diseases and Therapy|June 13, 2024
Treatment Patterns and Adherence to Guidelines for Uncomplicated Urinary Tract Infection in Germany: A Retrospective Cohort StudyAxel Krinner, Michael Schultze, Alen Marijam, et al.
Rheumatology and Therapy|February 5, 2021
The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource UtilizationAndreas Schwarting, Heiko Friedel, Elena Garal-Pantaler, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Deutsche Medizinische Wochenschrift (1946)|March 13, 2024
[Clinical courses and costs for hospitalizations of potentially immunocompromised COVID-19 patients in Germany]Dennis Häckl, Marc Pignot, Phi Long Dang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 11, 2023
Comorbidities, healthcare resource utilization & treatment pattern among patients with prurigo nodularis, compared to a benchmark in Germany: A real-world evidence claims data studySonja Ständer, Miriam Ketz, Divine Akumo, et al.
Acta Dermato-Venereologica|October 6, 2020
Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database AnalysisSonja Ständer, Miriam Ketz, Nils Kossack, et al.
Rheumatology and Therapy|November 24, 2023
Real-World Burden of Immunosuppressant-Treated Lupus Nephritis: A German Claims Database AnalysisElena Garal-Pantaler, Michael Schultze, Mary Elizabeth Georgiou, et al.
Acta Ophthalmologica|September 9, 2025
Epidemiology and burden of mild/moderate versus high myopia in Germany: A claims data analysisTarcyane Barata Garcia, Nils Kossack, Marc Pignot, et al.
Clinical and Experimental Rheumatology|February 12, 2026
Systemic lupus erythematosus and associated organ damage in real-world settings: estimating damage scores using administrative claims dataMichael Schultze, Elena Garal-Pantaler, Marc Pignot, et al.
BMC Rheumatology|May 16, 2024
Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in GermanyMichael Schultze, Elena Garal-Pantaler, Marc Pignot, et al.
Advances in Therapy|June 12, 2026
Incidence, Healthcare Resource Utilization, and Costs Associated with Intraoperative Ureteral Injuries: Evidence from a German Claims DatabaseBogdan Muresan, Tobias Heidler, Kirsten Leyland, et al.
Infectious Diseases and Therapy|June 13, 2024
Treatment Patterns and Adherence to Guidelines for Uncomplicated Urinary Tract Infection in Germany: A Retrospective Cohort StudyAxel Krinner, Michael Schultze, Alen Marijam, et al.
Rheumatology and Therapy|February 5, 2021
The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource UtilizationAndreas Schwarting, Heiko Friedel, Elena Garal-Pantaler, et al.
Pageof 3